AAV Quality Control Resource
SDS-PAGE reveals the overall protein composition of an AAV sample—most importantly the three capsid proteins VP1, VP2, and VP3—while Western Blot (WB) uses specific antibodies to confirm the identity of those same proteins and their relative signal. Because neither method proves that the capsid has packaged its genome, both are best read alongside titer and functional data within a complete viral vector analysis program.
Direct Answer
The AAV capsid is built from three structural proteins produced from the same cap gene by alternative splicing and start-codon usage. VP1, VP2, and VP3 are assembled into the icosahedral capsid at a roughly 1:1:10 ratio, and their presence and relative abundance are the most direct protein-level readouts of capsid composition.
Because the ratio shifts with serotype, production cell line, and purification conditions, it is treated as a consistency reference rather than an absolute pass/fail criterion. It is most informative when combined with genome titer and full/empty analysis.
The key principle: SDS-PAGE answers "which proteins are present and in what proportion," while Western Blot answers "is this specific protein present." The two are complementary, not interchangeable.
VP1u carries phospholipase A2 activity and nuclear localization signals important for endosomal escape and intracellular trafficking. A marked loss of VP1 can impair transduction.
VP2 is the least abundant structural protein and is resolved between VP1 and VP3 on a well-run gel.
VP3 is the most abundant protein and forms the bulk of the capsid shell, typically giving the strongest SDS-PAGE band.
The expected VP1:VP2:VP3 ratio is approximately 1:1:10, but actual values vary with serotype, production system, and process conditions.
Method Comparison
SDS-PAGE and Western Blot describe protein composition and identity; they do not measure genome content, full/empty ratio, or activity. Those questions require orthogonal methods such as qPCR/ddPCR, AUC, or AEX.
| Attribute | SDS-PAGE | Western Blot | Orthogonal QC |
|---|---|---|---|
| Principle | Separation by molecular weight after SDS denaturation | SDS-PAGE transfer plus antibody-specific detection | qPCR/ddPCR, AUC, AEX, TEM, HCP ELISA, etc. |
| Main AAV target | VP1/VP2/VP3 and other proteins | VP1/VP2/VP3 or a tagged/fusion protein | Genome titer, Full/Empty, morphology, residual impurities |
| Specificity | Low—shows all proteins present | High—confirms one target protein | Method-dependent, often quantitative |
| VP1/VP2/VP3 ratio | Relative comparison by band intensity | Assists signal analysis of a specific protein | Not applicable |
| Impurity detection | Visible extra bands (HCP/process proteins) | Only the probed target | HCP ELISA, residual DNA, endotoxin |
| Confirms packaging? | No | No | Yes—via genome titer and Full/Empty analysis |
| Best role | Composition, purity screen, process comparison | Identity confirmation, expression validation | Quantitative release and functional readouts |
Creative Biolabs applies SDS-PAGE and Western Blot within a broader analytical strategy that also includes genome titration and purity assessment. Explore AAV titration, purity of viral vector, and potency services for a complete quality picture.
Applications
In practice, the two methods sit at different points in the AAV workflow—from early Cap expression checks through release-adjacent characterization.
WB confirms VP1/VP2/VP3 expression when comparing packaging systems or constructs.
SDS-PAGE compares VP1/VP2/VP3 band positions, intensities, and relative ratios.
SDS-PAGE reveals extra bands suggestive of HCP or process-related impurities.
WB with anti-FLAG/HA/His or GFP antibodies validates tagged or engineered constructs.
Both methods compare purification processes and batch-to-batch protein profiles.
Method Design
The reliability of an SDS-PAGE or Western Blot result depends on sample handling, antibody choice, and run conditions. Control these so that the reported bands reflect the sample, not the method.
Buffer, denaturation, and reduction can shift band patterns. Keep loading amounts and matrix consistent across runs.
Use validated anti-AAV capsid antibodies (e.g., B1) or tag-specific antibodies, and include proper positive and negative controls.
For purified vector, use a defined loading basis such as capsid particles or vector genomes, and include a reference lot or protein standard where appropriate. Record the basis when comparing band intensity across samples.
VP1/VP2/VP3 migration and ratios differ across serotypes; establish references per serotype before setting thresholds.
Use SDS-PAGE for rapid screens and reserve WB for identity-critical or lower-abundance targets.
Both methods support characterization; quantitative release decisions require orthogonal, validated assays.
Result Interpretation
A stained gel and an immunoblot answer different questions. Read an unexpected band against the loading basis, reference lot, antibody specificity, and detection range before attributing it to a change in vector quality.
The band may represent a noncapsid protein or a capsid fragment that the antibody does not recognize. Compare with a reference preparation and use an identity-specific method if the assignment will affect a quality decision.
A lower-molecular-weight signal can suggest a capsid-derived species, but nonspecific binding and sample preparation also need consideration. Repeat with suitable controls and, when needed, confirm the protein identity by an orthogonal assay.
Compare equal loading bases, the same staining or antibody conditions, and a serotype-matched reference. Densitometry or immunoblot intensity alone may be affected by response factors and saturation; investigate a persistent shift alongside capsid and functional measurements.
Protein purity does not establish genome packaging or biological activity. Use genome titration, capsid-content analysis, and a relevant functional assay to locate the discrepancy rather than repeating the protein assay as the sole follow-up.
Decision Framework
The practical strategy is to deploy SDS-PAGE for fast, broad protein profiling and Western Blot for targeted identity confirmation, reserving quantitative methods for release decisions.
Choose SDS-PAGE: to compare VP1/VP2/VP3 profiles, ratios, and obvious impurities across fractions or batches.
Choose Western Blot: to verify that a band corresponds to a capsid protein or to detect a FLAG/HA/His/GFP tag.
Choose Western Blot: when a specific protein must be detected against a complex background.
Choose neither alone: pair with genome titration, Full/Empty analysis, and functional assays.
From Question to Evidence
Creative Biolabs can integrate SDS-PAGE and Western Blot into your AAV program alongside titer, purity, and potency analysis, delivering a single decision-ready characterization workflow.
Profile VP1, VP2, and VP3 alongside visible noncapsid bands with an appropriately normalized gel readout, then use a validated antibody when a band requires identity confirmation. Compare reference and test lots under matched conditions and document what the band pattern can—and cannot—establish for that serotype.
Measure vector genome concentration by an appropriate nucleic acid assay and add a transduction-based readout when the study requires functional titer. Review these results beside the capsid protein profile, with assay basis and sample normalization recorded so changes in genome signal are not interpreted as changes in capsid identity.
Use the protein profile to flag prominent noncapsid bands, then identify or quantify relevant impurities with suitable orthogonal assays. Evaluate empty and genome-containing particles separately, because a clean VP1/VP2/VP3 pattern does not determine capsid filling or exclude low-level process residues.
Assess the intended biological response in a relevant cell model with defined dose, sampling time, and controls. Compare potency with VP composition, genome titer, and capsid-content data to investigate discordant lots without assuming that a normal Western Blot predicts transduction.
Track VP band patterns and visible impurities across production lots or purification fractions using the same sample-preparation and detection conditions. A reproducible shift can direct follow-up of a process step, while orthogonal assays determine whether that shift also affects genome content, purity, or biological activity.
Selected Reading
Rose JA, Maizel JV Jr, Inman JK, Shatkin AJ. Structural proteins of adenovirus-associated viruses. J Virol. 1971;8(5):766-770. https://doi.org/10.1128/JVI.8.5.766-770.1971.
Grieger JC, Choi VW, Samulski RJ. Production and characterization of adeno-associated viral vectors. Nat Protoc. 2006;1(3):1412-1428. https://doi.org/10.1038/nprot.2006.207.
Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112(2):195-203. https://doi.org/10.1016/0003-2697(81)90281-5.
FAQ
Tell us about your project, and our experts will get back to you with a customized quote and proposal.
